Syneron Bio is a biotechnology company focused on the discovery and development of next-generation macrocyclic peptide therapeutics through its proprietary Synova™ platform.
The company builds a robust pipeline targeting oncology and chronic diseases and leverages drug development expertise and data science to advance therapeutic candidates.
Leadership & Board
Current Number of Employees13
Current LinkedIn Followers430
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$250M
Total Amount Raised$250M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$150M
Latest Funding Amount$150M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Syneron Bio had 13 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
13Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Syneron Bio had 430 followers as of September 14, 2026. The number of followers increased by 6 (1.42%) week-over-week.
430Latest Followers Count
6(1.42%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.